The Estradiol-Dihydrotestosterone model of prostate cancer

<p>Abstract</p> <p>Background</p> <p>The exact relationship between hormonal activity and prostate cancer(PCa) has not yet been clearly defined. One of the key hormones associated with PCa is testosterone(T). However, both <it>in vitro </it>and <it>in...

Full description

Bibliographic Details
Main Author: Friedman A Edward
Format: Article
Language:English
Published: BMC 2005-03-01
Series:Theoretical Biology and Medical Modelling
Online Access:http://www.tbiomed.com/content/2/1/10
id doaj-f2b853bfe27d4470b411c78e1d013876
record_format Article
spelling doaj-f2b853bfe27d4470b411c78e1d0138762020-11-24T21:41:37ZengBMCTheoretical Biology and Medical Modelling1742-46822005-03-01211010.1186/1742-4682-2-10The Estradiol-Dihydrotestosterone model of prostate cancerFriedman A Edward<p>Abstract</p> <p>Background</p> <p>The exact relationship between hormonal activity and prostate cancer(PCa) has not yet been clearly defined. One of the key hormones associated with PCa is testosterone(T). However, both <it>in vitro </it>and <it>in vivo </it>studies have shown that under some conditions T is capable of either promoting PCa growth or death. This article proposes a theory which resolves this apparent paradox.</p> <p>Model</p> <p>The Estradiol-Dihydrotestosterone(E-D) model introduced in this paper proposes that 17β-estradiol(E2) is essential for initiating the growth of PCa cells through the formation of telomeres. It also proposes that T is responsible for increasing the expression of proteins which cause apoptosis, or programmed cell death, and that 5α-dihydrotestosterone(DHT) is essential for preventing this. In addition, it is known that some T is converted to both E2 and DHT, which means that depending on the conditions, T is capable of either promoting the growth of or the killing of PCa.</p> http://www.tbiomed.com/content/2/1/10
collection DOAJ
language English
format Article
sources DOAJ
author Friedman A Edward
spellingShingle Friedman A Edward
The Estradiol-Dihydrotestosterone model of prostate cancer
Theoretical Biology and Medical Modelling
author_facet Friedman A Edward
author_sort Friedman A Edward
title The Estradiol-Dihydrotestosterone model of prostate cancer
title_short The Estradiol-Dihydrotestosterone model of prostate cancer
title_full The Estradiol-Dihydrotestosterone model of prostate cancer
title_fullStr The Estradiol-Dihydrotestosterone model of prostate cancer
title_full_unstemmed The Estradiol-Dihydrotestosterone model of prostate cancer
title_sort estradiol-dihydrotestosterone model of prostate cancer
publisher BMC
series Theoretical Biology and Medical Modelling
issn 1742-4682
publishDate 2005-03-01
description <p>Abstract</p> <p>Background</p> <p>The exact relationship between hormonal activity and prostate cancer(PCa) has not yet been clearly defined. One of the key hormones associated with PCa is testosterone(T). However, both <it>in vitro </it>and <it>in vivo </it>studies have shown that under some conditions T is capable of either promoting PCa growth or death. This article proposes a theory which resolves this apparent paradox.</p> <p>Model</p> <p>The Estradiol-Dihydrotestosterone(E-D) model introduced in this paper proposes that 17β-estradiol(E2) is essential for initiating the growth of PCa cells through the formation of telomeres. It also proposes that T is responsible for increasing the expression of proteins which cause apoptosis, or programmed cell death, and that 5α-dihydrotestosterone(DHT) is essential for preventing this. In addition, it is known that some T is converted to both E2 and DHT, which means that depending on the conditions, T is capable of either promoting the growth of or the killing of PCa.</p>
url http://www.tbiomed.com/content/2/1/10
work_keys_str_mv AT friedmanaedward theestradioldihydrotestosteronemodelofprostatecancer
AT friedmanaedward estradioldihydrotestosteronemodelofprostatecancer
_version_ 1725920989304324096